Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNABW) Change in Cash (2020 - 2025)

Historic Change in Cash for Ginkgo Bioworks Holdings (DNABW) over the last 6 years, with Q3 2025 value amounting to -$94.4 million.

  • Ginkgo Bioworks Holdings' Change in Cash rose 1734.66% to -$94.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$504.6 million, marking a year-over-year decrease of 1650.94%. This contributed to the annual value of -$383.8 million for FY2024, which is 101.16% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Change in Cash stood at -$94.4 million for Q3 2025, which was up 1734.66% from -$104.1 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Change in Cash ranged from a high of $1.5 billion in Q3 2021 and a low of -$250.3 million during Q1 2025
  • Moreover, its 5-year median value for Change in Cash was -$94.4 million (2025), whereas its average is -$12.0 million.
  • In the last 5 years, Ginkgo Bioworks Holdings' Change in Cash soared by 11396.5% in 2022 and then plummeted by 53635.49% in 2023.
  • Ginkgo Bioworks Holdings' Change in Cash (Quarter) stood at -$172.4 million in 2021, then soared by 113.96% to $24.1 million in 2022, then plummeted by 536.35% to -$105.0 million in 2023, then soared by 46.88% to -$55.8 million in 2024, then plummeted by 69.17% to -$94.4 million in 2025.
  • Its Change in Cash was -$94.4 million in Q3 2025, compared to -$104.1 million in Q2 2025 and -$250.3 million in Q1 2025.